/
IBO
$0.43-$0.01 (-1.57%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$48.2M
108M shares
52-week range
$0.37 – $0.83
12% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
XASE
CS
Change$-2.24
Impact BioMedical, Inc.
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
www.impactbiomedinc.com- Employees
- 8
- IPO / List date
- Sep 16, 2024
- HQ
- HOUSTON, TX
Held by traders on TradeandTell
No one on the platform currently holds IBO.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in IBO as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded IBO yet.
